Quantification of fibrin degradation products in glioma and meningioma patients.

Background: DR-70 is an immunoassay for fibrin and FDP in plasma and it has been shown useful in detection of over 14 different cancers. This study investigated the validity of the DR-70 test in gliomas as well as meningiomas.

Methods: 77 brain tumor patients as well as 40 healthy individuals were prospectively included in the study and investigated using DR-70 kit.